ATE437631T1 - Pharmazeutische zusammensetzung von mikrokügelchen zur verhinderung einer amputation eines diabetischen fusses - Google Patents

Pharmazeutische zusammensetzung von mikrokügelchen zur verhinderung einer amputation eines diabetischen fusses

Info

Publication number
ATE437631T1
ATE437631T1 AT07702319T AT07702319T ATE437631T1 AT E437631 T1 ATE437631 T1 AT E437631T1 AT 07702319 T AT07702319 T AT 07702319T AT 07702319 T AT07702319 T AT 07702319T AT E437631 T1 ATE437631 T1 AT E437631T1
Authority
AT
Austria
Prior art keywords
microbeadles
pharmaceutical composition
diabetic foot
amputation
preventing
Prior art date
Application number
AT07702319T
Other languages
English (en)
Inventor
Rodriguez Blas Yamir Betancourt
Martoenez Vivian Maria Saez
Meireles Rolando Paez
Acosta Jorge Amador Berlanga
Hernandez Jose Angel Raman
Original Assignee
Ct Ingenieria Genetica Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38185604&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE437631(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ct Ingenieria Genetica Biotech filed Critical Ct Ingenieria Genetica Biotech
Application granted granted Critical
Publication of ATE437631T1 publication Critical patent/ATE437631T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1808—Epidermal growth factor [EGF] urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AT07702319T 2006-01-31 2007-01-29 Pharmazeutische zusammensetzung von mikrokügelchen zur verhinderung einer amputation eines diabetischen fusses ATE437631T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CU20060021A CU23388B6 (es) 2006-01-31 2006-01-31 Composición farmacéutica de microesferas para prevenir la amputación del pie diabético
PCT/CU2007/000002 WO2007087759A2 (es) 2006-01-31 2007-01-29 Composición farmacéutica de microesferas para prevenir la amputación del pie diabético

Publications (1)

Publication Number Publication Date
ATE437631T1 true ATE437631T1 (de) 2009-08-15

Family

ID=38185604

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07702319T ATE437631T1 (de) 2006-01-31 2007-01-29 Pharmazeutische zusammensetzung von mikrokügelchen zur verhinderung einer amputation eines diabetischen fusses

Country Status (24)

Country Link
US (1) US8741848B2 (de)
EP (1) EP1987817B1 (de)
JP (1) JP5219841B2 (de)
KR (1) KR101401273B1 (de)
CN (2) CN101400338A (de)
AR (1) AR059234A1 (de)
AT (1) ATE437631T1 (de)
AU (1) AU2007211753B2 (de)
BR (1) BRPI0707395A2 (de)
CA (1) CA2640743C (de)
CU (1) CU23388B6 (de)
CY (1) CY1109513T1 (de)
DE (1) DE602007001786D1 (de)
DK (1) DK1987817T3 (de)
ES (1) ES2330688T3 (de)
HK (1) HK1198743A1 (de)
MY (1) MY143742A (de)
PL (1) PL1987817T3 (de)
PT (1) PT1987817E (de)
RU (1) RU2426528C2 (de)
SG (1) SG169366A1 (de)
SI (1) SI1987817T1 (de)
WO (1) WO2007087759A2 (de)
ZA (1) ZA200806648B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU23411B6 (es) * 2005-12-29 2009-09-08 Ct Ingenieria Genetica Biotech Uso tópico del factor de crecimiento epidérmico en liposomas para prevenir la amputación del pie diabético
ES2340902B1 (es) 2008-07-01 2011-05-03 Laboratorios Farmaceuticos Rovi, S.A. Composicion farmaceutica con glicosaminoglicanos y su uso en tratamiento de ulceras cronicas.
GB0814302D0 (en) 2008-08-05 2008-10-01 Coretherapix Slu Compounds and methods
KR101156094B1 (ko) * 2010-02-22 2012-06-20 경상대학교산학협력단 약물송달을 위한 양친성 ＰＨＡ－ｍＰＥＧ 공중합 나노 컨테이너
ES2357601B1 (es) 2011-01-26 2012-03-21 Laboratorios Farmacéuticos Rovi, S.A. Procedimiento de preparación de derivados de glicosaminoglicanos donadores de óxido n�?trico y su uso en tratamiento de úlceras crónicas.
EP2737895A1 (de) 2012-11-30 2014-06-04 Praxis Pharmaceutical, S.A. Mikropartikel mit EGF, Herstellungsverfahren und Verwendung
EP2821077A1 (de) 2013-07-04 2015-01-07 Praxis Biopharma Research Institute Lipid-Nanopartikel zur Wundheilung
EP3097922A1 (de) 2015-05-28 2016-11-30 Denis Barritault Zusammensetzung für die behandlung von gewebeläsionen
CN106267163A (zh) * 2015-06-09 2017-01-04 济南博创医药科技有限公司 一种治疗皮肤创伤的药物组合物及其药物制剂
MX2016016339A (es) * 2016-12-09 2018-06-08 Desarrolladora Y Com De Tecnologias Biomedicas Decotecbio S A S De C V Composicion coadyuvante de un factor de crecimiento y un neuropeptido para acelerar la cicatrizacion de heridas y la repitelizacion de organos.
KR102218427B1 (ko) * 2017-09-20 2021-02-22 차의과학대학교 산학협력단 단백질 약물을 포함하는 코아세르베이트 조성물 및 이를 포함하는 창상 치료제
CU20190022A7 (es) * 2019-03-18 2020-10-20 Centro De Ingenieria Genetica Y Biotecnologia Biocubafarma Composición farmacéutica para el tratamiento de la úlcera del pie diabético

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE52535B1 (en) 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
JPS60100516A (ja) 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
NZ226171A (en) 1987-09-18 1990-06-26 Ethicon Inc Gel formulation containing polypeptide growth factor
JP2670680B2 (ja) * 1988-02-24 1997-10-29 株式会社ビーエムジー 生理活性物質含有ポリ乳酸系微小球およびその製造法
US5034375A (en) 1988-08-10 1991-07-23 Institute Of Molecular Biology, Inc. Process of wound healing using PDGF and EGF
US4944948A (en) * 1989-02-24 1990-07-31 Liposome Technology, Inc. EGF/Liposome gel composition and method
WO1990011781A1 (en) 1989-04-04 1990-10-18 Alcon Laboratories, Inc. The use of liposomes for the delivery of therapeutic agents to wounds, cuts and abrasions
US5130298A (en) * 1989-05-16 1992-07-14 Ethicon, Inc. Stabilized compositions containing epidermal growth factor
JPH04501123A (ja) 1989-08-01 1992-02-27 ザ　ユニヴァーシティ　オブ　ミシガン 脱水／水補給リポソームに被嚢されたペプチド／タンパク質の局所送達
AU629316B2 (en) 1990-04-11 1992-10-01 Flora Inc. Periodontal disease treatment system
US6902743B1 (en) * 1995-05-22 2005-06-07 The United States Of America As Represented By The Secretary Of The Army Therapeutic treatment and prevention of infections with a bioactive material(s) encapuslated within a biodegradable-bio-compatable polymeric matrix
AU725654B2 (en) * 1996-05-03 2000-10-19 Innogenetics N.V. New medicaments containing gelatin cross-linked with oxidized polysaccharides
US5861149A (en) * 1997-06-04 1999-01-19 Polyheal Ltd. Methods for wound treatment
EP2316490A3 (de) * 2000-10-31 2012-02-01 PR Pharmaceuticals, Inc. Verfahren und Formulierungen zur verbesserten Abgabe von bioaktiven Molekülen
HK1077740A1 (en) * 2001-12-20 2006-02-24 Ct Ingenieria Genetica Biotech Use of epidermal growth factor in the manufacture of a pharmaceutical injection composition for preventing diabetic limb amputation
WO2003075949A1 (en) 2002-03-12 2003-09-18 Bio-Click Technologies Ltd. Method and composition for treating skin wounds with epidermal growth factor
CN1720989A (zh) * 2004-07-15 2006-01-18 深圳市清华源兴生物医药科技有限公司 一种表皮生长因子缓释微球及其制备方法与应用
CU23411B6 (es) * 2005-12-29 2009-09-08 Ct Ingenieria Genetica Biotech Uso tópico del factor de crecimiento epidérmico en liposomas para prevenir la amputación del pie diabético

Also Published As

Publication number Publication date
EP1987817B1 (de) 2009-07-29
US20090220608A1 (en) 2009-09-03
KR20080096804A (ko) 2008-11-03
EP1987817A2 (de) 2008-11-05
KR101401273B1 (ko) 2014-05-29
CA2640743A1 (en) 2007-08-09
JP5219841B2 (ja) 2013-06-26
CN101400338A (zh) 2009-04-01
AU2007211753A1 (en) 2007-08-09
RU2426528C2 (ru) 2011-08-20
WO2007087759A2 (es) 2007-08-09
PL1987817T3 (pl) 2010-01-29
MY143742A (en) 2011-07-15
AR059234A1 (es) 2008-03-19
CA2640743C (en) 2012-05-15
RU2008135354A (ru) 2010-03-10
ES2330688T3 (es) 2009-12-14
CY1109513T1 (el) 2014-08-13
US8741848B2 (en) 2014-06-03
HK1198743A1 (en) 2015-06-05
CN103933552A (zh) 2014-07-23
CU23388B6 (es) 2009-07-16
BRPI0707395A2 (pt) 2011-05-03
WO2007087759A3 (es) 2007-09-20
SG169366A1 (en) 2011-03-30
JP2009525288A (ja) 2009-07-09
SI1987817T1 (sl) 2009-12-31
PT1987817E (pt) 2009-10-26
DK1987817T3 (da) 2009-11-30
ZA200806648B (en) 2009-05-27
AU2007211753B2 (en) 2012-03-01
DE602007001786D1 (de) 2009-09-10

Similar Documents

Publication Publication Date Title
ATE437631T1 (de) Pharmazeutische zusammensetzung von mikrokügelchen zur verhinderung einer amputation eines diabetischen fusses
DE602007002909D1 (de) Geschoss zur verabreichung eines medikaments
BRPI0809977A2 (pt) Uso de um composto, compostos e composição farmacêutica que o contém
BRPI0919942A2 (pt) Composto, composição farmacêutica, e, uso de um composto
BRPI0907562A2 (pt) composto, composição farmacêutica, e, uso de um composto
BRPI0914174A2 (pt) Estruturas absorventes que incluem um material absorvente revestido
ATE489078T1 (de) Pharmazeutische zusammensetzungen mit rosuvastatin-calcium
ATE517619T1 (de) Stabilisierte pharmazeutische zusammensetzung mit fesoterodin
BRPI0906046A2 (pt) "artigo absorvente tendo um sinal de umidade olfativo"
BRPI0810161A2 (pt) Composto, preparação farmacêutica, composição farmacêutica, e, uso de um composto
BRPI0921879A2 (pt) composto, composição farmacêutica , e, uso de um composto
BRPI0918360A2 (pt) composto, composição farmacêutica e usos de um composto
BRPI0917579A2 (pt) composto, composição farmacêutica, métodos, e, uso de um composto
BRPI0905680A2 (pt) "composição farmacêutica de uma composição farmacêutica"
BRPI0813961A2 (pt) Composição herbicida sinérgica contendo um derivado do ácido fenóxi alcanoico substituído e um derivado de glifosato
ATE493119T1 (de) Pharmazeutische zusammensetzung
CL2007003082A1 (es) Compuestos derivados de dihidropirazolonas; procedimiento de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar enfermedades cardiocirculatorias, insuficiencia cardiaca, anemia, enfermedad renal cronica e in
BRPI0810019A2 (pt) Composto, composição farmacêutica, e, uso de um composto
BRPI0716698A2 (pt) Composto, composição farmacêutica e uso de um composto
BRPI0812942A2 (pt) Composto, composição farmacêutica e uso de um composto
BRPI0919165A2 (pt) composição farmacêutica,e, uso de um composto
FR2926996B1 (fr) Composition pharmaceutique a proprietes gelifiantes contenant un derive de tyrosine
DK2075004T3 (da) Anvendelse af epidermal vækstfaktor til morphofunktionel genoprettelse af perifere nerver ved diabetisk neuropati
CL2007003841A1 (es) Compuestos derivados de 4(5h-1 lambda-tiazol-2-il)piperidina; composicion farmaceutica que contiene a dichos compuestos; y su uso para tratar diabetes.
ATE480227T1 (de) Pharmazeutische zusammensetzungen mit quetiapinfumarat

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1987817

Country of ref document: EP